[新型抗结核药物] - Suppr | 超能文献

[New antitubercular drugs].

作者信息

Krasucka-Kluźniak A

机构信息

Kliniki Gruźlicy i Chorób Płuc Instytutu Gruźlicy i Chorób Płuc.

出版信息

Pneumonol Pol. 1990 Apr-May;58(4-5):163-6.

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

[New antitubercular drugs].[新型抗结核药物]

Pneumonol Pol. 1990 Apr-May;58(4-5):163-6.

2

Minimal inhibitory concentrations of rifabutin, ciprofloxacin, and ofloxacin against Mycobacterium tuberculosis isolated before treatment of patients in Taiwan.在台湾，利福布汀、环丙沙星和氧氟沙星对患者治疗前分离出的结核分枝杆菌的最低抑菌浓度。

Am Rev Respir Dis. 1989 Oct;140(4):987-9. doi: 10.1164/ajrccm/140.4.987.

3

In vitro and in vivo chemotherapeutic activity of rifabutin (LM 427) on Mycobacterium avium-intracellulare complex.利福布汀（LM 427）对鸟分枝杆菌-胞内分枝杆菌复合体的体外和体内化疗活性。

Bull Chest Dis Res Inst Kyoto Univ. 1987 Mar;20(1-2):50-60.

4

Drugs for tuberculosis.治疗结核病的药物。

Treat Guidel Med Lett. 2004 Dec;2(28):83-8.

5

[Activities of rifabutine and rifampicin against Mycobacterium avium complex infections in mice and in peritoneal macrophages].利福布汀和利福平对小鼠及腹膜巨噬细胞中鸟分枝杆菌复合群感染的活性

Kekkaku. 1988 Mar;63(3):173-9.

6

[Evaluation of new antitubercular agents--new quinolone agents].新型抗结核药物——新型喹诺酮类药物的评估

Kekkaku. 1992 Oct;67(10):679-82.

7

[Comparison of in-vitro and in-vivo activities of enoxacin and ofloxacin against the Mycobacterium tuberculosis].依诺沙星和氧氟沙星对结核分枝杆菌的体外和体内活性比较

Zhonghua Jie He He Hu Xi Za Zhi. 1995 Jun;18(3):175-7, 192.

8

Varying effects of common tuberculosis drugs on enhancing clofazimine activity in vitro.常用抗结核药物对增强氯法齐明体外活性的不同作用。

Emerg Microbes Infect. 2017 Apr 26;6(4):e28. doi: 10.1038/emi.2017.24.

9

[Studies on therapeutic efficacy of a new anti-tuberculous drug, benzoxazinorifamycin, against murine experimental mycobacterial infections: attempt at various regimens and protocols].[新型抗结核药物苯并恶嗪诺利福霉素对小鼠实验性分枝杆菌感染的治疗效果研究：多种治疗方案和规程的尝试]

Kekkaku. 1994 Nov;69(11):703-10.

10

Prospects for development of new antimycobacterial drugs, with special reference to a new benzoxazinorifamycin, KRM-1648.新型抗分枝杆菌药物的研发前景，特别提及新型苯并恶嗪利福霉素KRM-1648

Arch Immunol Ther Exp (Warsz). 2000;48(3):183-8.

引用本文的文献

1

Daily ingestion of Akkermansia mucciniphila for one month promotes healthy aging and increases lifespan in old female mice.连续一个月每天摄入阿克曼氏菌（Akkermansia muciniphila）可促进老年雌性小鼠健康衰老并延长其寿命。

Biogerontology. 2022 Feb;23(1):35-52. doi: 10.1007/s10522-021-09943-w. Epub 2021 Nov 2.